News >

Blood Cancer Treatment Continues to Shift Away From Chemotherapy

Jessica Hergert
Published: Thursday, Sep 05, 2019

Steven T. Rosen, MD, director of the Irell & Manella Graduate School of Biological Sciences, professor in the Department of Hematology and Hematopoietic Cell Transplantation, at City of Hope

Steven T. Rosen, MD

In recent years, successful trials exploring novel approaches such as targeted therapy, immunotherapy, and CAR T-cell therapy, have all revolutionized the way certain hematologic malignancies are treated. Newer agents are garnering the same, if not better, results than what has been seen with traditional approaches, such as chemotherapy, according to Steven T. Rosen, MD.
... to read the full story
To Read the Full Story

View Conference Coverage
Online CME Activities
TitleExpiration DateCME Credits
2nd Annual Live Medical Crossfire®: Hematologic Malignancies OnlineSep 28, 20198.0
Community Practice Connections™: 2nd Annual School of Nursing Oncology™Sep 28, 20191.5
Publication Bottom Border
Border Publication
x